625 results on '"Skokowa, Julia"'
Search Results
2. Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patients
3. Correction: NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells
4. CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia
5. A JAGN1-associated severe congenital neutropenia zebrafish model revealed an altered G-CSFR signaling and UPR activation
6. CD19-immunoPET for noninvasive visualization of CD19 expression in B-cell lymphoma patients
7. Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
8. Identification of GFI1 mutations in adult patients with congenital neutropenia
9. The design of functional proteins using tensorized energy calculations
10. CRISPR/Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia
11. A topological refactoring design strategy yields highly stable granulopoietic proteins
12. A unique role of p53 haploinsufficiency or loss in the development of acute myeloid leukemia with FLT3-ITD mutation
13. Chronic neutropenic colitis with complete colonic obstruction in a patient with severe congenital neutropenia associated with G6PC3 mutations
14. Neutropenie im Kindesalter
15. Tuning of granulopoietic signaling byde novodesigned agonists
16. SRP54 mutations induce congenital neutropenia via dominant-negative effects on XBP1 splicing
17. CRISPR-Cas9n-mediated ELANEpromoter editing for gene therapy of severe congenital neutropenia
18. NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells
19. P779: LONG-TERM COURSE OF HAX1-RELATED CONGENITAL NEUTROPENIA: AN ANALYSIS OF THE EUROPEAN SEVERE CHRONIC NEUTROPENIA INTERNATIONAL REGISTRY (SCNIR)
20. P780: G-CSF THERAPY IN EUROPEAN PATIENTS WITH SHWACHMAN-DIAMOND SYNDROME
21. S178: A NEW HEREDITARY SYNDROME WITH SEVERE NEUTROPENIA AND NEUROLOGICAL INVOLVEMENT CAUSED BY THE AUTOSOMAL RECESSIVE COPZ1 MUTATION
22. P751: UNRAVELING THE DIFFERENT PATHOMECHANISMS OF CONGENITAL AND CYCLIC NEUTROPENIAS: CYCLIC EXPRESSION OF HEMATOPOIETIC STEM-CELL-SPECIFIC TRANSCRIPTION FACTORS IN CYCLIC NEUTROPENIA
23. P1357: MILESTONE (MODIFYING ELANE GOLDBERG–HOGNES BOX TO INHIBIT EXPRESSION), A UNIVERSAL, SAFE AND EFFECTIVE CRISPR/CAS9N-MEDIATED GENOME EDITING STRATEGY FOR ELANE RELATED SEVERE CONGENITAL NEUTROPENIA
24. P458: HIPSC DISEASE MODELING TO STUDY LEUKEMIA DEVELOPMENT IN HAX1 VS ELANE ASSOCIATED CONGENITAL NEUTROPENIA
25. PB1703: MODELING T-CELL DEVELOPMENT AND T-ALL INITIATION
26. Cooperating, congenital neutropenia–associated Csf3r and Runx1 mutations activate pro-inflammatory signaling and inhibit myeloid differentiation of mouse HSPCs
27. LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis
28. Lentiviral gene therapy and vitamin B3 treatment enable granulocytic differentiation of G6PC3-deficient induced pluripotent stem cells
29. Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34+ cells preceding leukemic transformation
30. HAX1‐related congenital neutropenia: Long‐term observation in paediatric and adult patients enrolled in the European branch of the Severe Chronic Neutropenia International Registry ( SCNIR )
31. CRISPR/Cas9 Genome Editing of Human-Induced Pluripotent Stem Cells Followed by Granulocytic Differentiation
32. Gene Knockout in Hematopoietic Stem and Progenitor Cells Followed by Granulocytic Differentiation
33. The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: A Consensus Between the European Hematology Association and the EuNet-INNOCHRON COST Action
34. Immunneutropenien im Kindesalter
35. Differential Expression of C/Ebpa and Its Stem Cell-Specific Targets in Congenital Neutropenias and Cyclic Neutropenias
36. Accumulation of Specific Somatic Leukemia-Associated Mutations in Congenital Neutropenia Precedes Malignant Transformation - New Preconditions for Treatment Decisions
37. Corrigendum to ‘Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34+ cells preceding leukemic transformation’ <[Experimental Hematology, Volume 71, 2019;71:51−60]>
38. Regenerative medicine meets translational oncology: Modeling leukemic bone marrow niche
39. GM-CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling
40. Release of the pre-assembled naRNA-LL37 composite DAMP re-defines neutrophil extracellular traps (NETs) as intentional DAMP webs
41. Generation, expansion, and drug treatment of hematopoietic progenitor cells derived from human iPSCs
42. Bortezomib inhibits STAT5-dependent degradation of LEF-1, inducing granulocytic differentiation in congenital neutropenia CD34+ cells
43. Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis
44. A lack of secretory leukocyte protease inhibitor (SLPI) causes defects in granulocytic differentiation
45. High-content cytometry and transcriptomic biomarker profiling of human B-cell activation
46. Development of a First-in-Class Small-Molecule Inhibitor of the C-Terminal Hsp90 Dimerization
47. CLPB in neutropenia: 1 gene with many faces
48. Old drug revisited: disulfiram, NETs, and sepsis
49. Development of a First-in-Class Small Molecule Inhibitor of the C-terminal Hsp90 Dimerization
50. A unique role of p53 haploinsufficiency or loss in the development of acute myeloid leukemia with FLT3-ITD mutation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.